Skip to main content
Back to HSG

HSG's Biotechnology Portfolio

Browse 19 Biotechnology companies funded by HSG. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
19
Total Funding in Biotechnology
$1.6B

Biotechnology Portfolio Companies (19)

Export
BiotechnologyLife ScienceOncologyPharmaceutical

ArriVent develops pharmaceutical products to cure presently untreatable cancer.

Pennsylvania Furnace, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Deep Intelligent Pharma is a Singapore based AI Clinical Trial Company

Singapore, Singapore
March 2026
$40.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.

New Haven, United States
January 2025
$75.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareHealth Diagnostics

Spear Bio is a biotech company that focuses on the detection of ultrasensitive protein.

Weston, United States
July 2024
$45.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyOncologyTherapeutics

ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.

Seattle, United States
February 2024
$112.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceuticalProduct Research

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

New York, United States
January 2024
$100.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

PackGene Biotech provides CRO/CDMO services for gene therapy and cell therapy researchers and developers.

Houston, United States
December 2023
$14.1M
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalPharmaceutical

Cullgen is a drug discovery services intended to create new drugs for the treatment of diseases that currently lack effective therapies.

San Diego, United States
May 2023
$35.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyNeuroscience

SciNeuro is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases.

Rockville, United States
December 2025
$53.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

19,000+ verified contacts

BiotechnologyClinical TrialsMedicalMedical Device

Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.

Menlo Park, United States
January 2026
$67.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceutical

HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.

Suzhou, China
December 2025
$17.1M
Debt Financing

Founder Contacts

19,000+ verified contacts

BiotechnologyLife SciencePharmaceutical

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

Wuxi Shi, China
December 2025
$108.0M
Series B

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

South San Francisco, United States
December 2025
$747.5M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyLife ScienceMedicalTherapeutics

Proviva Therapeutics is a pro-drug design platform for cytokines and other fusion proteins.

Shanghai, China
December 2025
$30.0M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth Care

Generation Lab measures molecular disbalance a marker of aging using a straightforward cheek-swab test combined with patented methodologies.

San Francisco, United States
October 2025
$11.0M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyMedical DevicePharmaceutical

METiS Pharmaceuticals is the world's first AI-driven drug formulation company.

Hangzhou, China
August 2025
$55.7M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.

Suzhou, China
July 2025
$59.7M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Biotechnology

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Shanghai, China
July 2025
$19.5M
Series D

Founder Contacts

19,000+ verified contacts

Explore HSG's Full Portfolio

View all companies funded by HSG across every industry and funding stage.

View Full HSG Portfolio